Terms: = Thyroid cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Clinical Outcome
32 results:
1. Presumed Pathogenic Germ Line and Somatic Variants in African American thyroid cancer.
Hurst ZA; Liyanarachchi S; Brock P; He H; Nabhan F; Veloski C; Toland AE; Ringel MD; Jhiang SM
Thyroid; 2024 Mar; 34(3):378-387. PubMed ID: 38062767
[No Abstract] [Full Text] [Related]
2. BRAF
Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
[TBL] [Abstract] [Full Text] [Related]
3. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of factors influencing the clinical outcome after surgery and
Li Y; Rao M; Zheng C; Huang J; Fang D; Xiong Y; Yuan G
Front Endocrinol (Lausanne); 2022; 13():1015798. PubMed ID: 36313750
[TBL] [Abstract] [Full Text] [Related]
5. Potential Impact of Body Mass Index on the clinical outcome of Papillary thyroid cancer After High-Dose Radioactive Iodine Therapy.
Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of Diagnostic Value of SPECT/CT Imaging in Post-radioiodine Therapy in thyroid cancer.
Al Hatmi A; Jain A; Mittal AK; Hussain S
Sultan Qaboos Univ Med J; 2022 Feb; 22(1):74-81. PubMed ID: 35299812
[TBL] [Abstract] [Full Text] [Related]
7. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated thyroid cancer Patients: A Retrospective Study in Southwest China.
Liu Q; Yin M; Li G
Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
[TBL] [Abstract] [Full Text] [Related]
8. Cutoff Age Between Pediatric and Adult thyroid Differentiated cancer: Is 18 Years Old Appropriate?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Yoshioka K; Ito K
Thyroid; 2022 Feb; 32(2):145-152. PubMed ID: 34549602
[No Abstract] [Full Text] [Related]
9. HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic thyroid cancer Cell Line.
Hegedűs L; Rittler D; Garay T; Stockhammer P; Kovács I; Döme B; Theurer S; Hager T; Herold T; Kalbourtzis S; Bankfalvi A; Schmid KW; Führer D; Aigner C; Hegedűs B
Pathol Oncol Res; 2020 Oct; 26(4):2523-2535. PubMed ID: 32591993
[TBL] [Abstract] [Full Text] [Related]
10. Histopathologic Features and clinical outcome of Anaplastic thyroid Carcinoma with a Minor Anaplastic Component.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
[TBL] [Abstract] [Full Text] [Related]
11. Retrospective Cohort Study of 1947 thyroid Nodules: A Comparison of the 2017 American College of Radiology TI-RADS and the 2015 American thyroid Association Classifications.
Pandya A; Caoili EM; Jawad-Makki F; Wasnik AP; Shankar PR; Bude R; Haymart MR; Davenport MS
AJR Am J Roentgenol; 2020 Apr; 214(4):900-906. PubMed ID: 32069084
[No Abstract] [Full Text] [Related]
12. Potential Impact of BMI on the Aggressiveness of Presentation and clinical outcome of Differentiated thyroid cancer.
Matrone A; Ceccarini G; Beghini M; Ferrari F; Gambale C; D'Aqui M; Piaggi P; Torregrossa L; Molinaro E; Basolo F; Vitti P; Santini F; Elisei R
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31875910
[TBL] [Abstract] [Full Text] [Related]
13. DELAYED 131-I FIRST TREatmENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM outcome OF PATIENTS WITH INTERMEDIate RISK DIFFERENTIateD thyroid cancer.
Matrone A; Gambale C; Torregrossa L; Piaggi P; Bianchi F; Valerio L; Viola D; Agate L; Molinaro E; Materazzi G; Basolo F; Vitti P; Elisei R
Endocr Pract; 2020 Jan; 26(1):58-71. PubMed ID: 31557080
[No Abstract] [Full Text] [Related]
14. Radioguided occult lesion localization in patients with recurrent thyroid cancer.
Tuncel M; Süslü N
Eur Arch Otorhinolaryngol; 2019 Jun; 276(6):1757-1766. PubMed ID: 30887167
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic thyroid Carcinomas.
Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
[No Abstract] [Full Text] [Related]
16. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
[TBL] [Abstract] [Full Text] [Related]
17. Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer.
Guo LC; Zhu WD; Ma XY; Ni H; Zhong EJ; Shao YW; Yu J; Gu DM; Ji SD; Xu HD; Ji C; Yang JM; Zhang Y
Cancer Biol Ther; 2019; 20(3):240-246. PubMed ID: 30252567
[TBL] [Abstract] [Full Text] [Related]
18. Anaplastic thyroid carcinoma in Denmark 1996-2012: A national prospective study of 219 patients.
Hvilsom GB; Londero SC; Hahn CH; Schytte S; Pedersen HB; Christiansen P; Kiss K; Larsen SR; Jespersen ML; Lelkaitis G; Godballe C
Cancer Epidemiol; 2018 Apr; 53():65-71. PubMed ID: 29414634
[TBL] [Abstract] [Full Text] [Related]
19. Utility of adult-based ultrasound malignancy risk stratifications in pediatric thyroid nodules.
Martinez-Rios C; Daneman A; Bajno L; van der Kaay DCM; Moineddin R; Wasserman JD
Pediatr Radiol; 2018 Jan; 48(1):74-84. PubMed ID: 28983667
[TBL] [Abstract] [Full Text] [Related]
20. Dynamic risk stratification for predicting the recurrence in differentiated thyroid cancer.
Ozkan E; Soydal C; Nak D; Kucuk NO; Kir KM
Nucl Med Commun; 2017 Dec; 38(12):1055-1059. PubMed ID: 28957841
[TBL] [Abstract] [Full Text] [Related]
[Next]
